ID   COMP_RAT                Reviewed;         755 AA.
AC   P35444;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   29-MAY-2024, entry version 163.
DE   RecName: Full=Cartilage oligomeric matrix protein {ECO:0000305};
DE            Short=COMP;
DE   Flags: Precursor;
GN   Name=Comp {ECO:0000312|RGD:2378};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cartilage;
RX   PubMed=1429587; DOI=10.1016/s0021-9258(18)41677-8;
RA   Oldberg A., Antonsson P., Lindblom K., Heinegaard D.;
RT   "COMP (cartilage oligomeric matrix protein) is structurally related to the
RT   thrombospondins.";
RL   J. Biol. Chem. 267:22346-22350(1992).
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH ITGA7.
RX   PubMed=20019333; DOI=10.1161/circresaha.109.202762;
RA   Wang L., Zheng J., Du Y., Huang Y., Li J., Liu B., Liu C.J., Zhu Y.,
RA   Gao Y., Xu Q., Kong W., Wang X.;
RT   "Cartilage oligomeric matrix protein maintains the contractile phenotype of
RT   vascular smooth muscle cells by interacting with alpha(7)beta(1)
RT   integrin.";
RL   Circ. Res. 106:514-525(2010).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 27-72, AND DISULFIDE BONDS.
RX   PubMed=8864111; DOI=10.1126/science.274.5288.761;
RA   Malashkevich V.N., Kammerer R.A., Efimov V.P., Schulthess T., Engel J.;
RT   "The crystal structure of a five-stranded coiled coil in COMP: a prototype
RT   ion channel?";
RL   Science 274:761-765(1996).
CC   -!- FUNCTION: Plays a role in the structural integrity of cartilage via its
CC       interaction with other extracellular matrix proteins such as the
CC       collagens and fibronectin. Can mediate the interaction of chondrocytes
CC       with the cartilage extracellular matrix through interaction with cell
CC       surface integrin receptors. Could play a role in the pathogenesis of
CC       osteoarthritis. Potent suppressor of apoptosis in both primary
CC       chondrocytes and transformed cells. Suppresses apoptosis by blocking
CC       the activation of caspase-3 and by inducing the IAP family of survival
CC       proteins (BIRC3, BIRC2, BIRC5 and XIAP) (By similarity). Essential for
CC       maintaining a vascular smooth muscle cells (VSMCs)
CC       contractile/differentiated phenotype under physiological and
CC       pathological stimuli. Maintains this phenotype of VSMCs by interacting
CC       with ITGA7 (PubMed:20019333). {ECO:0000250|UniProtKB:P49747,
CC       ECO:0000269|PubMed:20019333}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P49747};
CC       Note=Binds 11-14 calcium ions per subunit.
CC       {ECO:0000250|UniProtKB:P49747};
CC   -!- SUBUNIT: Pentamer; disulfide-linked. Exists in a more compact
CC       conformation in the presence of calcium and shows a more extended
CC       conformation in the absence of calcium. Interacts with ITGB3, ITGA5 and
CC       FN1. Binding to FN1 requires the presence of divalent cations (Ca(2+),
CC       Mg(2+) or Mn(2+)). The greatest amount of binding is seen in the
CC       presence of Mn(2+). Interacts with MATN1, MATN3, MATN4 and ACAN. Binds
CC       heparin, heparan sulfate and chondroitin sulfate. EDTA dimishes
CC       significantly its binding to ACAN and abolishes its binding to MATN3,
CC       MATN4 and chondroitin sulfate. Interacts with collagen I, II and IX,
CC       and interaction with these collagens is dependent on the presence of
CC       zinc ions. Interacts with ADAMTS12 (By similarity). Interacts with
CC       ITGA7 (PubMed:20019333). {ECO:0000250|UniProtKB:P49747,
CC       ECO:0000269|PubMed:20019333}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250|UniProtKB:P49747}.
CC   -!- DOMAIN: The cell attachment motif mediates the attachment to
CC       chondrocytes. It mediates the induction of both the IAP family of
CC       survival proteins and the antiapoptotic response.
CC       {ECO:0000250|UniProtKB:P49747}.
CC   -!- DOMAIN: The TSP C-terminal domain mediates interaction with FN1 and
CC       ACAN. {ECO:0000250|UniProtKB:P49747}.
CC   -!- DOMAIN: Each of the eight TSP type-3 repeats binds two calcium ions.
CC       The TSP C-terminal domain binds three calcium ions.
CC       {ECO:0000250|UniProtKB:P49747}.
CC   -!- SIMILARITY: Belongs to the thrombospondin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X72914; CAA51419.1; -; mRNA.
DR   PIR; A44315; A44315.
DR   RefSeq; NP_036966.1; NM_012834.1.
DR   PDB; 1FBM; X-ray; 2.70 A; A/B/C/D/E=28-72.
DR   PDB; 1VDF; X-ray; 2.05 A; A/B/C/D/E=28-72.
DR   PDB; 6SF6; X-ray; 1.90 A; C/D=232-250.
DR   PDBsum; 1FBM; -.
DR   PDBsum; 1VDF; -.
DR   PDBsum; 6SF6; -.
DR   AlphaFoldDB; P35444; -.
DR   SMR; P35444; -.
DR   BioGRID; 247343; 2.
DR   STRING; 10116.ENSRNOP00000067037; -.
DR   GlyCosmos; P35444; 2 sites, No reported glycans.
DR   GlyGen; P35444; 2 sites.
DR   PhosphoSitePlus; P35444; -.
DR   PaxDb; 10116-ENSRNOP00000067037; -.
DR   ABCD; P35444; 1 sequenced antibody.
DR   GeneID; 25304; -.
DR   KEGG; rno:25304; -.
DR   AGR; RGD:2378; -.
DR   CTD; 1311; -.
DR   RGD; 2378; Comp.
DR   eggNOG; ENOG502QRK8; Eukaryota.
DR   InParanoid; P35444; -.
DR   OrthoDB; 5345349at2759; -.
DR   PhylomeDB; P35444; -.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   EvolutionaryTrace; P35444; -.
DR   PRO; PR:P35444; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:RGD.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0036122; F:BMP binding; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005518; F:collagen binding; ISO:RGD.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IDA:RGD.
DR   GO; GO:0001968; F:fibronectin binding; IDA:RGD.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0043394; F:proteoglycan binding; ISO:RGD.
DR   GO; GO:0005499; F:vitamin D binding; IMP:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0007596; P:blood coagulation; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0098868; P:bone growth; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0060349; P:bone morphogenesis; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:1990079; P:cartilage homeostasis; ISS:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; ISO:RGD.
DR   GO; GO:0002063; P:chondrocyte development; ISO:RGD.
DR   GO; GO:0035988; P:chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISO:RGD.
DR   GO; GO:0003416; P:endochondral bone growth; ISO:RGD.
DR   GO; GO:0003417; P:growth plate cartilage development; ISO:RGD.
DR   GO; GO:0060173; P:limb development; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0055001; P:muscle cell development; ISO:RGD.
DR   GO; GO:0050881; P:musculoskeletal movement; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1900047; P:negative regulation of hemostasis; ISO:RGD.
DR   GO; GO:0050905; P:neuromuscular process; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; ISO:RGD.
DR   GO; GO:0009306; P:protein secretion; ISO:RGD.
DR   GO; GO:0030500; P:regulation of bone mineralization; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0006986; P:response to unfolded protein; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0035989; P:tendon development; ISO:RGD.
DR   GO; GO:0097084; P:vascular associated smooth muscle cell development; ISO:RGD.
DR   GO; GO:0014829; P:vascular associated smooth muscle contraction; ISO:RGD.
DR   CDD; cd00054; EGF_CA; 2.
DR   CDD; cd16077; TSP-5cc; 1.
DR   Gene3D; 1.20.5.10; -; 1.
DR   Gene3D; 2.60.120.200; -; 1.
DR   Gene3D; 2.10.25.10; Laminin; 4.
DR   Gene3D; 4.10.1080.10; TSP type-3 repeat; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   InterPro; IPR003367; Thrombospondin_3-like_rpt.
DR   InterPro; IPR017897; Thrombospondin_3_rpt.
DR   InterPro; IPR008859; Thrombospondin_C.
DR   InterPro; IPR039081; TSP-5_cc.
DR   InterPro; IPR024665; TSP/COMP_coiled-coil.
DR   InterPro; IPR046970; TSP/COMP_coiled-coil_sf.
DR   InterPro; IPR028974; TSP_type-3_rpt.
DR   PANTHER; PTHR10199:SF88; CARTILAGE OLIGOMERIC MATRIX PROTEIN; 1.
DR   PANTHER; PTHR10199; THROMBOSPONDIN; 1.
DR   Pfam; PF11598; COMP; 1.
DR   Pfam; PF07645; EGF_CA; 2.
DR   Pfam; PF02412; TSP_3; 6.
DR   Pfam; PF05735; TSP_C; 1.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00179; EGF_CA; 2.
DR   SUPFAM; SSF58006; Assembly domain of cartilage oligomeric matrix protein; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF103647; TSP type-3 repeat; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS01187; EGF_CA; 2.
DR   PROSITE; PS51234; TSP3; 8.
DR   PROSITE; PS51236; TSP_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Calcium; Cell adhesion; Disulfide bond;
KW   EGF-like domain; Extracellular matrix; Glycoprotein; Heparin-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..755
FT                   /note="Cartilage oligomeric matrix protein"
FT                   /id="PRO_0000035859"
FT   DOMAIN          85..124
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          125..177
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          178..220
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          223..265
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          266..298
FT                   /note="TSP type-3 1"
FT   REPEAT          299..334
FT                   /note="TSP type-3 2"
FT   REPEAT          335..357
FT                   /note="TSP type-3 3"
FT   REPEAT          358..393
FT                   /note="TSP type-3 4"
FT   REPEAT          394..416
FT                   /note="TSP type-3 5"
FT   REPEAT          417..454
FT                   /note="TSP type-3 6"
FT   REPEAT          455..490
FT                   /note="TSP type-3 7"
FT   REPEAT          491..526
FT                   /note="TSP type-3 8"
FT   DOMAIN          530..744
FT                   /note="TSP C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00635"
FT   REGION          21..84
FT                   /note="COMP N-terminal"
FT   REGION          295..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          525..755
FT                   /note="Mediates cell survival and induction of the IAP
FT                   family of survival proteins"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        298..312
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        333..381
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        410..442
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0G6"
FT   CARBOHYD        119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        740
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        68
FT                   /note="Interchain (with C-71)"
FT                   /evidence="ECO:0000269|PubMed:8864111,
FT                   ECO:0007744|PDB:1FBM, ECO:0007744|PDB:1VDF"
FT   DISULFID        71
FT                   /note="Interchain (with C-68)"
FT                   /evidence="ECO:0000269|PubMed:8864111,
FT                   ECO:0007744|PDB:1FBM, ECO:0007744|PDB:1VDF"
FT   DISULFID        89..100
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        94..109
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        112..123
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        129..140
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        134..149
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        152..176
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        182..195
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        189..204
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        207..219
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        227..241
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        235..251
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        253..264
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        280..285
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        290..310
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        326..346
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        349..369
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        385..405
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        408..428
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        446..466
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        482..502
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        518..739
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   HELIX           30..66
FT                   /evidence="ECO:0007829|PDB:1VDF"
SQ   SEQUENCE   755 AA;  82664 MW;  AB48888FE093C598 CRC64;
     MSPTACVLVL ALAALRATGQ GQIPLGGDLA PQMLRELQET NAALQDVREL LRHRVKEITF
     LKNTVMECDA CGMQPARTPG LSVRPVALCA PGSCFPGVVC TETATGARCG PCPPGYTGNG
     SHCTDVNECN AHPCFPRVRC INTSPGFHCE ACPPGFSGPT HEGVGLTFAK TNKQVCTDIN
     ECETGQHNCV PNSVCVNTRG SFQCGPCQPG FVGDQRSGCQ RRGQHFCPDG SPSPCHEKAD
     CILERDGSRS CVCAVGWAGN GLLCGRDTDL DGFPDEKLRC SERQCRKDNC VTVPNSGQED
     VDRDRIGDAC DPDADGDGVP NEQDNCPLVR NPDQRNSDKD KWGDACDNCR SQKNDDQKDT
     DRDGQGDACD DDIDGDRIRN VADNCPRVPN FDQSDSDGDG VGDACDNCPQ KDNPDQRDVD
     HDFVGDACDS DQDQDGDGHQ DSRDNCPTVP NSAQQDSDHD GKGDACDDDD DNDGVPDSRD
     NCRLVPNPGQ EDNDRDGVGD ACQGDFDADK VIDKIDVCPE NAEVTLTDFR AFQTVVLDPE
     GDAQIDPNWV VLNQGMEIVQ TMNSDPGLAV GYTAFNGVDF EGTFHVNTAT DDDYAGFIFG
     YQDSSSFYVV MWKQMEQTYW QANPFRAVAE PGIQLKAVKS STGPGEQLRN ALWHTGDTAS
     QVRLLWKDPR NVGWKDKTSY RWFLQHRPQV GYIRVRFYEG PELVADSNVV LDTAMRGGRL
     GVFCFSQENI IWANLRYRCN DTIPEDYERH RLRRA
//
